HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Avon: Firm will increase its full-year advertising for fiscal 2007 to $375 mil., 50% more than was allocated for the prior year and almost three times its 2005 investment of $136 mil., Avon CEO and Chairman Andrea Jung indicated Sept. 6 at the Lehman Brothers Back-to-School Consumer Conference. The initial plan for FY 2007 was to increase ad spend by 35% versus 2006. Heavy spending on advertising is part of Avon's turnaround initiative announced in 2005 (1"The Rose Sheet" Nov. 21, 2005, p. 3). The initiative is delivering results, Jung said; revenue was up 12% in Q2 2007, with beauty sales climbing 14% and sales in Brazil, Russia, Columbia, Turkey and China growing in the double-digits...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel